✦ LIBER ✦

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

✍ Scribed by Yukari Shirasugi; Kiyoshi Ando; Koji Miyazaki; Yoshiaki Tomiyama; Shinichiro Okamoto; Mineo Kurokawa; Keita Kirito; Yuji Yonemura; Shinichiro Mori; Kensuke Usuki; Koji Iwato; Satoshi Hashino; Helen Wei; Richard Lizambri

Book ID: 107619330
Publisher: Carden Jennings Publishing
Year: 2011
Tongue: English
Weight: 392 KB
Volume: 94
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-011-0886-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: randomized, double-blind

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4

✍ J. F. ROSSIGNOL; S. M. KABIL; Y. EL-GOHARY; A. ELFERT; E. B. KEEFFE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Antiviral activity, dose–response relati

Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

✍ Michiko Shindo; Kazuaki Chayama; Satoshi Mochida; Joji Toyota; Eiichi Tomita; Hi 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia

✍ K. Meijer; E. B. Haagsma; J. Van Der Meer; for the CHARIBDIS Study Group 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

A phase III randomized double-blind plac

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

✍ Mark M. Schubert; Fernanda P. Eduardo; Katherine A. Guthrie; Jean-Claude Franqui 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 304 KB

Silodosin, a new α1A-adrenoceptor-select

Silodosin, a new α1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men

✍ Kazuki Kawabe; Masaki Yoshida; Yukio Homma; for the Silodosin Clinical Study Gro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views